Search

everythinglearnresearchcommunity

for

Search:↓

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Baricitinib was effective in treating alopecia areata in two major trials.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Photobiomodulation may help reduce pain and inflammation in knee osteoarthritis, but its long-term benefits are unclear.

Reporter characteristics affect detection of hair loss from cancer therapy.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Thulium laser therapy is a safe and effective short-term treatment for hair regrowth.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Thulium laser therapy is a safe and effective short-term treatment for hair regrowth in androgenic alopecia patients.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.